Search Results - AVORN, Jerry

Refine Results
  1. 1
    The Marketplace Can't Give Us the Drug Safety Data We Need

    The Marketplace Can't Give Us the Drug Safety Data We Need by Avorn, Jerry

    Published 2007
    Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Every Clinician Deserves an Un-Sales Rep

    Every Clinician Deserves an Un-Sales Rep by Avorn, Jerry

    Published 2007
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Economic Consequences of Underuse of Generic Drugs: Evidence from Medicaid and Implications for Prescription Drug Benefit Plans

    Economic Consequences of Underuse of Generic Drugs: Evidence from Medicaid and Implications for Prescription Drug Benefit Plans by Fischer, Michael A, Avorn, Jerry

    Published 2003
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    LETTERS TO THE EDITOR

    LETTERS TO THE EDITOR by Ganz, David A, Avorn, Jerry

    Published 2001
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    A substantial cause of preventable illness

    A substantial cause of preventable illness by Avorn, Jerry, Shrank, William H

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Clinicians’ Contributions to the Development of Coronary Artery Stents: A Qualitative Study of Transformative Device Innovation

    Clinicians’ Contributions to the Development of Coronary Artery Stents: A Qualitative Study of Transformative Device Innovation by Kesselheim, Aaron S., Xu, Shuai, Avorn, Jerry

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Medicaid Expenditures and Estimated Rebates for Epinephrine Autoinjectors, 2012 to 2016

    Medicaid Expenditures and Estimated Rebates for Epinephrine Autoinjectors, 2012 to 2016 by Luo, Jing, Kesselheim, Aaron S., Avorn, Jerry

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    US Taxpayers Heavily Funded the Discovery of COVID‐19 Vaccines

    US Taxpayers Heavily Funded the Discovery of COVID‐19 Vaccines by Lalani, Hussain S., Avorn, Jerry, Kesselheim, Aaron S.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration

    Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration by Feldman, Daniel, Avorn, Jerry, Kesselheim, Aaron S.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Pharmacoepidemiology and in silico drug evaluation: is there common ground?

    Pharmacoepidemiology and in silico drug evaluation: is there common ground? by Stürmer, Til, Rothman, Kenneth J., Avorn, Jerry

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases

    Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases by Rassen, Jeremy A., Avorn, Jerry, Schneeweiss, Sebastian

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review

    Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review by Austad, Kirsten E., Avorn, Jerry, Kesselheim, Aaron S.

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Risk, responsibility, and generic drugs

    Risk, responsibility, and generic drugs by Kesselheim, Aaron S., Avorn, Jerry, Greene, Jeremy A.

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Public sector financial support for late stage discovery of new drugs in the United States: cohort study

    Public sector financial support for late stage discovery of new drugs in the United States: cohort study by Nayak, Rahul K, Avorn, Jerry, Kesselheim, Aaron S

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Potential Medicare Savings on Inhaler Prescriptions Through the Use of Negotiated Prices and a Defined Formulary

    Potential Medicare Savings on Inhaler Prescriptions Through the Use of Negotiated Prices and a Defined Formulary by Feldman, William B., Avorn, Jerry, Kesselheim, Aaron S.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 Pandemic

    Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 Pandemic by Rome, Benjamin N., Avorn, Jerry, Kesselheim, Aaron S.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Pharmaceutical cost containment with reference-based pricing: time for refinements

    Pharmaceutical cost containment with reference-based pricing: time for refinements by Schneeweiss, Sebastian, Maclure, Malcolm, Dormuth, Colin, Avorn, Jerry

    Published 2002
    Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Use of Health Care Databases to Support Supplemental Indications of Approved Medications

    Use of Health Care Databases to Support Supplemental Indications of Approved Medications by Fralick, Michael, Kesselheim, Aaron S., Avorn, Jerry, Schneeweiss, Sebastian

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Variations in Generic Combination Opioid Use Across State Medicaid Programs

    Variations in Generic Combination Opioid Use Across State Medicaid Programs by Lee, ChangWon C., Kesselheim, Aaron S., Avorn, Jerry

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Improved Comorbidity Adjustment for Predicting Mortality in Medicare Populations

    Improved Comorbidity Adjustment for Predicting Mortality in Medicare Populations by Schneeweiss, Sebastian, Wang, Philip S, Avorn, Jerry, Glynn, Robert J

    Published 2003
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: